GUMDROP : JHMI ECALGB90601 - A Randomized double-blinded Phase III study comparing Gemcitabine, Cisplatin, and Bevacizumab to Gemcitabine, Cisplatin and placebo in patients with advanced Transitional Cell Carcinoma
Created by Channing Paller, last modified on Apr 14, 2012
Description: |
Hist-confirmed metastatic TCC of the urinary tract (T4b, N2, N3, or M1); NO prior combination chemotherapy; prior neoadjuvant or adjuvant systemic chemo ok |
Link: |
http://clinicaltrials.gov/ct2/show/NCT00234494
|
Site: |
Johns Hopkins Hospital |
Principal Investigator: |
Jenny Kim, M.D. |